These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23646964)

  • 1. The enigma of placebo effects in drug-refractory epilepsies.
    Krämer G
    Epilepsia; 2013 May; 54 Suppl 2():13-5. PubMed ID: 23646964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: reply to Beyenburg et al., 2009.
    Rheims S; Perucca E; Ryvlin P
    Epilepsia; 2010 May; 51(5):935-6. PubMed ID: 20536532
    [No Abstract]   [Full Text] [Related]  

  • 3. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
    Rogawski MA
    Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.
    Beyenburg S; Stavem K; Schmidt D
    Epilepsia; 2010 Jan; 51(1):7-26. PubMed ID: 19744114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
    Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
    Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New antiepileptic drugs in childhood epilepsies: indications and limits].
    Kaminska A
    Epileptic Disord; 2001; 3 Spec No 2():SI37-46. PubMed ID: 11827845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory epilepsy: clinical overview.
    French JA
    Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo responses in randomized trials of antiepileptic drugs.
    Guekht AB; Korczyn AD; Bondareva IB; Gusev EI
    Epilepsy Behav; 2010 Jan; 17(1):64-9. PubMed ID: 19919904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology aspects during transition and at transfer in patients with epilepsy.
    Chiron C; An I
    Epilepsia; 2014 Aug; 55 Suppl 3():8-11. PubMed ID: 25209078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
    Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
    Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The new antiepileptic drugs: their indications and side effects].
    Malagón-Valdez J
    Rev Neurol; 2004 Sep 16-30; 39(6):570-5. PubMed ID: 15467997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacological treatment of epilepsy in adults.
    Perucca E; Tomson T
    Lancet Neurol; 2011 May; 10(5):446-56. PubMed ID: 21511198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying baseline characteristics of placebo responders versus nonresponders in randomized double-blind trials of refractory partial-onset seizures.
    Niklson I; Edrich P; Verdru P
    Epileptic Disord; 2006 Mar; 8(1):37-44. PubMed ID: 16567324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current challenges in the treatment of epilepsy.
    Mattson RH
    Neurology; 1994 Jun; 44(6 Suppl 5):S4-9; discussion S31-2. PubMed ID: 8022538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.
    Schmidt D; Löscher W
    Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epilepsy surgery, antiepileptic drug trials, and the role of evidence.
    Janszky J; Kovacs N; Gyimesi C; Fogarasi A; Doczi T; Wiebe S
    Epilepsia; 2010 Jun; 51(6):1004-9. PubMed ID: 20384716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview on antiepileptic drugs.
    Das N; Dhanawat M; Shrivastava SK
    Drug Discov Ther; 2012 Aug; 6(4):178-93. PubMed ID: 23006988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo and nocebo responses in drug trials of epilepsy.
    Zaccara G; Giovannelli F; Schmidt D
    Epilepsy Behav; 2015 Feb; 43():128-34. PubMed ID: 25703333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The case for assessing cannabidiol in epilepsy.
    Cilio MR; Thiele EA; Devinsky O
    Epilepsia; 2014 Jun; 55(6):787-90. PubMed ID: 24854434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.